The reversion of CLL cytoskeleton to microvillus structure following imatinib-treatment of CLL lymphocytes therefore, is entirely consistent with an importance for ABL1-dependent signalling in the cells. Here, ABL1 is linked to B-cell chronic lymphocytic leukemia.